Absorption Enhancer and Polymer (Vitamin E TPGS and PVP K29) by Solid Dispersion Improve Dissolution and Bioavailability of Eprosartan Mesylate

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Bulletin of The Korean Chemical Society

• Publication date

  2011-05-20

• Fields of study

  Medicine, Materials Science, Chemistry

• Identifiers
  DOI 10.5012/BKCS.2011.32.5.1587
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Simultaneous determination of amoxicillin and ambroxol in human plasma by LC-MS/MS: validation and application to pharmacokinetic study.

  2008influential reference
• Determination of eprosartan in human plasma and urine by LC/MS/MS.

  2007cited by this paper
• Influence of vitamin E TPGS poly(ethylene glycol) chain length on apical efflux transporters in Caco-2 cell monolayers.

  2006cited by this paper
• Determination of ambroxol in human plasma using LC-MS/MS.

  2003influential reference
• Promoting mechanism of menthol derivative, 1-O-ethyl-3-buthylcyclohexanol, on the percutaneous absorption of ketoprofen.

  2001cited by this paper
• Improving drug solubility for oral delivery using solid dispersions.

  2000cited by this paper
• Eprosartan

  2000cited by this paper
• Properties of Hot-Melt Extruded Theophylline Tablets Containing Poly(Vinyl Acetate)

  2000influential reference
• Effect of synthesized cyclohexanol derivatives using L-menthol as a lead compound on the percutaneous absorption of ketoprofen.

  2000cited by this paper
• Influence of vitamin E TPGS on the properties of hydrophilic films produced by hot-melt extrusion.

  2000cited by this paper
• Properties of sustained-release tablets prepared by hot-melt extrusion.

  1999influential reference
• Pharmacokinetics of intravenously and orally administered eprosartan in healthy males: absolute bioavailability and effect of food

  1998cited by this paper
• A Dose Proportionality Study of Eprosartan in Healthy Male Volunteers

  1998cited by this paper
• Pharmaceutical applications of solid dispersion systems.

  1971cited by this paper

• Ibrutinib amorphous solid dispersions with enhanced dissolution at colonic pH for the localized treatment of colorectal cancer.

  2023cites this paper
• A nano-enclatherated-gel-composite for the treatment of alcohol abuse and addiction

  2022cites this paper
• Formulation and characterization of eprosartan mesylate and β-cyclodextrin inclusion complex prepared by microwave technology

  2022cites this paper
• Preparation and Evaluation of Eprosartan Mesylate loaded PLGA Nanostructures

  2022cites this paper
• Development of Apremilast Solid Dispersion Using TPGS and PVPVA with Enhanced Solubility and Bioavailability

  2021cites this paper
• Polyethylene Glycol-Based Solid Dispersions to Enhance Eprosartan Mesylate Dissolution and Bioavailability

  2019cites this paper
• Pravastatin, a 3-hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA) reductase inhibitor, is a synthetic cholesterol-lowering agent that belongs to statin class [1]. Pravastatin competitively inhibits HMG-CoA reductase, the rate-limiting enzyme in the cholesterol biosynthesis pathway, which eventually red

  2018cites this paper
• Polyvinylpyrrolidone Behavior in Water/Ethanol Mixed Solvents: Comparison of Modeling Predictions with Experimental Results

  2017cites this paper
• Enteric coated capsules of eprosartan mesylate with pH-modifier for augmenting the dissolution

  2016cites this paper
• MODIFICATION OF PHYSIOCHEMICAL PROPERTIES OF OLMESARTAN MEDOXIMIL USING VARIOUS CARRIERS & VITAMIN E TPGS AS A SOLUBLISER

  2016cites this paper
• Formulation and Evaluation of Immediate Release Tablets of Eprosartan Mesylate

  2014cites this paper
• The applications of Vitamin E TPGS in drug delivery.

  2013cites this paper
• Advanced formulation and processing technologies in the oral delivery of poorly water-soluble drugs

  2013cites this paper